226 related articles for article (PubMed ID: 33537097)
1. Mutation of SPINOPHILIN (PPP1R9B) found in human tumors promotes the tumorigenic and stemness properties of cells.
Verdugo-Sivianes EM; Rojas AM; Muñoz-Galván S; Otero-Albiol D; Carnero A
Theranostics; 2021; 11(7):3452-3471. PubMed ID: 33537097
[No Abstract] [Full Text] [Related]
2. SPINOPHILIN: A multiplayer tumor suppressor.
Verdugo-Sivianes EM; Carnero A
Genes Dis; 2023 Jan; 10(1):187-198. PubMed ID: 37013033
[TBL] [Abstract][Full Text] [Related]
3. Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors.
Ferrer I; Verdugo-Sivianes EM; Castilla MA; Melendez R; Marin JJ; Muñoz-Galvan S; Lopez-Guerra JL; Vieites B; Ortiz-Gordillo MJ; De León JM; Praena-Fernandez JM; Perez M; Palacios J; Carnero A
Oncogene; 2016 May; 35(21):2777-88. PubMed ID: 26387546
[TBL] [Abstract][Full Text] [Related]
4. Role of the Holoenzyme PP1-SPN in the Dephosphorylation of the RB Family of Tumor Suppressors During Cell Cycle.
Verdugo-Sivianes EM; Carnero A
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34066428
[TBL] [Abstract][Full Text] [Related]
5. Spinophilin acts as a tumor suppressor by regulating Rb phosphorylation.
Ferrer I; Blanco-Aparicio C; Peregrina S; Cañamero M; Fominaya J; Cecilia Y; Lleonart M; Hernandez-Losa J; Ramon y Cajal S; Carnero A
Cell Cycle; 2011 Aug; 10(16):2751-62. PubMed ID: 21772120
[TBL] [Abstract][Full Text] [Related]
6. Spinophilin loss correlates with poor patient prognosis in advanced stages of colon carcinoma.
Estevez-Garcia P; Lopez-Calderero I; Molina-Pinelo S; Muñoz-Galvan S; Salinas A; Gomez-Izquierdo L; Lucena-Cacace A; Felipe-Abrio B; Paz-Ares L; Garcia-Carbonero R; Carnero A
Clin Cancer Res; 2013 Jul; 19(14):3925-35. PubMed ID: 23729363
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of spinophilin in lung tumours contributes to tumourigenesis.
Molina-Pinelo S; Ferrer I; Blanco-Aparicio C; Peregrino S; Pastor MD; Alvarez-Vega J; Suarez R; Verge M; Marin JJ; Hernandez-Losa J; Ramon y Cajal S; Paz-Ares L; Carnero A
J Pathol; 2011 Sep; 225(1):73-82. PubMed ID: 21598252
[TBL] [Abstract][Full Text] [Related]
8. Spinophilin: a new tumor suppressor at 17q21.
Carnero A
Curr Mol Med; 2012 Jun; 12(5):528-35. PubMed ID: 22515982
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms Regulating the Association of Protein Phosphatase 1 with Spinophilin and Neurabin.
Edler MC; Salek AB; Watkins DS; Kaur H; Morris CW; Yamamoto BK; Baucum AJ
ACS Chem Neurosci; 2018 Nov; 9(11):2701-2712. PubMed ID: 29786422
[TBL] [Abstract][Full Text] [Related]
10. Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer.
Ress AL; Stiegelbauer V; Schwarzenbacher D; Deutsch A; Perakis S; Ling H; Ivan C; Calin GA; Rinner B; Gerger A; Pichler M
Oncotarget; 2014 Sep; 5(18):8492-502. PubMed ID: 25261368
[TBL] [Abstract][Full Text] [Related]
11. Flexibility in the PP1:spinophilin holoenzyme.
Ragusa MJ; Allaire M; Nairn AC; Page R; Peti W
FEBS Lett; 2011 Jan; 585(1):36-40. PubMed ID: 21094159
[TBL] [Abstract][Full Text] [Related]
12. Spinophilin loss contributes to tumorigenesis in vivo.
Ferrer I; Peregrino S; Cañamero M; Cecilia Y; Blanco-Aparicio C; Carnero A
Cell Cycle; 2011 Jun; 10(12):1948-55. PubMed ID: 21670604
[TBL] [Abstract][Full Text] [Related]
13. Protein Phosphatase 1 binds strongly to the retinoblastoma protein but not to p107 or p130 in vitro and in vivo.
Dunaief JL; King A; Esumi N; Eagen M; Dentchev T; Sung CH; Chen S; Zack DJ
Curr Eye Res; 2002 May; 24(5):392-6. PubMed ID: 12434308
[TBL] [Abstract][Full Text] [Related]
14. A Mutant p53-Dependent Embryonic Stem Cell Gene Signature Is Associated with Augmented Tumorigenesis of Stem Cells.
Koifman G; Shetzer Y; Eizenberger S; Solomon H; Rotkopf R; Molchadsky A; Lonetto G; Goldfinger N; Rotter V
Cancer Res; 2018 Oct; 78(20):5833-5847. PubMed ID: 30154152
[TBL] [Abstract][Full Text] [Related]
15. Orai1 promotes tumor progression by enhancing cancer stemness via NFAT signaling in oral/oropharyngeal squamous cell carcinoma.
Lee SH; Rigas NK; Lee CR; Bang A; Srikanth S; Gwack Y; Kang MK; Kim RH; Park NH; Shin KH
Oncotarget; 2016 Jul; 7(28):43239-43255. PubMed ID: 27259269
[TBL] [Abstract][Full Text] [Related]
16. Low spinophilin expression enhances aggressive biological behavior of breast cancer.
Schwarzenbacher D; Stiegelbauer V; Deutsch A; Ress AL; Aigelsreiter A; Schauer S; Wagner K; Langsenlehner T; Resel M; Gerger A; Ling H; Ivan C; Calin GA; Hoefler G; Rinner B; Pichler M
Oncotarget; 2015 May; 6(13):11191-202. PubMed ID: 25857299
[TBL] [Abstract][Full Text] [Related]
17. RB, p130 and p107 differentially repress G1/S and G2/M genes after p53 activation.
Schade AE; Fischer M; DeCaprio JA
Nucleic Acids Res; 2019 Dec; 47(21):11197-11208. PubMed ID: 31667499
[TBL] [Abstract][Full Text] [Related]
18. Distinct Roles of Protein Phosphatase 1 Bound on Neurabin and Spinophilin and Its Regulation in AMPA Receptor Trafficking and LTD Induction.
Gao J; Hu XD; Yang H; Xia H
Mol Neurobiol; 2018 Sep; 55(9):7179-7186. PubMed ID: 29383693
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the neuronal targeting protein spinophilin and its interactions with protein phosphatase-1.
Hsieh-Wilson LC; Allen PB; Watanabe T; Nairn AC; Greengard P
Biochemistry; 1999 Apr; 38(14):4365-73. PubMed ID: 10194355
[TBL] [Abstract][Full Text] [Related]
20. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
